Kempex
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Kempex - overview
Established
1987
Location
-, -, Netherlands
Primary Industry
Consumer Products
About
Kempex Holland BV is a Netherlands-based company specializing in high-quality animal feed additives and Active Pharmaceutical Ingredients (APIs), catering to the veterinary and agricultural sectors with effective solutions for animal health management. Kempex Holland BV, founded in 1987, operates in the Netherlands and focuses on supplying animal feed additives and APIs. The company was acquired by MKB Fonds in May 2013, enhancing its operational capabilities. The founder's history and any notable previous ventures are not documented.
Kempex Holland BV specializes in high-quality animal feed additives and Active Pharmaceutical Ingredients (APIs). Their offerings include vitamins, minerals, anthelmintics, antimicrobials, and essential feed additives aimed at enhancing animal nutrition and health. The company ensures effective solutions for livestock production efficiency and serves a diverse clientele across Europe, the Middle East, and global markets, including veterinarians, farmers, and manufacturers. Additionally, Kempex acts as the exclusive distributor for LongMarch in Europe, a GMP-certified manufacturer of veterinary pharmaceuticals, further solidifying their product reliability.
Kempex Holland BV operates on a B2B model, supplying products through direct partnerships with distributors and wholesalers in the veterinary and agricultural sectors. The revenue structure revolves around the sales of their trademarked products, highlighting their commitment to quality and traceability. Their revenue is primarily generated from ongoing partnerships with stakeholders in the animal health sector, ensuring a consistent supply of essential products. The EBITDA for the most recent year, 2023, is reported at EUR 819,677.
Kempex Holland BV plans to expand its product portfolio by launching new animal feed additives in 2024, focusing on innovative formulations to enhance livestock health. The company is targeting growth in the Middle Eastern and Asian markets by 2025, leveraging recent strategic funding. The recent acquisition in May 2013 has positioned Kempex to utilize additional resources to support these expansion initiatives.
Current Investors
MKB Fonds
Primary Industry
Consumer Products
Sub Industries
Pet Products
Website
https://www.kempex.net/
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
Kempex - financials
| Fiscal Year Ended | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | - | - | - | - | - | - | - | - | - | - |
| % Revenue Growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| EBITDA (USD) | 549,157 | 937,345 | 1,058,553 | 1,098,456 | 897,181 | 729,293 | 1,853,004 | - | - | - |
| Operating Income (USD) | 505,796 | 891,701 | 1,011,454 | 1,046,917 | 845,002 | 679,935 | 1,815,772 | - | - | - |
| Operating Margin | - | - | - | - | - | - | - | - | - | - |
| % EBITDA Margin | - | - | - | - | - | - | - | - | - | - |
| NET Income (USD) | 133,956 | 481,593 | 510,787 | 593,801 | 418,075 | 388,795 | 1,251,062 | - | - | - |
| % Net Margin | - | - | - | - | - | - | - | - | - | - |
Kempex - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | Tocelo Vet | - | ||||||||
| Buyout | Completed | Kempex | - |
Displaying 1 - 2 of 2
Kempex - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.